Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?

Severe lymphopenia after subcutaneous cladribine in a patient with multiple sclerosis: To vaccinate or not?

Objective: To describe a fatal case of influenza A pneumonia in a patient with severe lymphopenia after receiving subcutaneous cladribine to treat her multiple sclerosis (MS). Methods: Case report. Results: A 53-year-old woman developed fatal influenza pneumonia associated with grade 4 lymphopenia t...

Full description

Bibliographic Details
Main Authors: M. Mateo-Casas, S. Reyes, S. De Trane, F. Edwards, M. Espasandin, G. Anjorin, D. Baker, K. Schmierer, G. Giovannoni
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:eNeurologicalSci
Subjects:
Cladribine
Disease-modifying treatment
Lymphopenia
Adverse event
Influenza A virus
Multiple Sclerosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2405650220300587

Similar Items

Similar Items